BioPorto Diagnostics A/S
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
- In Vitro Diagnostics
- Chemistry, Immunoassay
Latest on BioPorto Diagnostics A/S
IN VITRO DIAGNOSTICS Alliances Allergan PLC T2 Biosystems Inc. T2 Biosystems Inc. and Allergan PLC are teaming up to develop a diagnostic panel to detect Gram-negative bacteria and antibiotic
Company Changes COOPER , Todd To: Presbia PLC , Pres. & CEO (January) From: NVISION Laser Eye Centers, VP, General Mgr. Phone: 949-502-7010 DI RUSSO , Gregory B., MD To: CytoSorbents Corp.
New At The Helm Company Changes ASHBURN , Theodore T., MD, PhD To: Dicerna Pharmaceuticals Inc. , SVP, Product Strategy & Ops. (December) From: Genzyme/Sanofi Oncology, Global Product Leader, Le
Device Transactions Medtech fundraising totaled $714 million in 2014’s opening quarter, a significant decrease – just over 40% – from Q4 2013’s $1.2 billion. ( See Exhibit 1. ) Exhibit 1 Q1 2014 Devic